Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy
Authors
Keywords
-
Journal
GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-05
DOI
10.1038/s41434-021-00300-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision
- (2020) Hendrik Neubert et al. CLINICAL CHEMISTRY
- Absolute Quantification of Dystrophin Protein in Human Muscle Biopsies using Parallel Reaction Monitoring (PRM)
- (2019) Emily H. Canessa et al. JOURNAL OF MASS SPECTROMETRY
- Human FcRn Tissue Expression Profile and Half-Life in PBMCs
- (2019) Yao-Yun Fan et al. Biomolecules
- Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development
- (2019) Kitipong Uaesoontrachoon et al. Biomarkers in Medicine
- 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
- (2019) Steven Piccoli et al. Bioanalysis
- Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage
- (2018) Jeffrey R. Whiteaker et al. DNA REPAIR
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples
- (2018) Valentina Sardone et al. PLoS One
- Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy
- (2018) Chantal Beekman et al. PLoS One
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Quantitative Analysis of Human Neonatal Fc Receptor (FcRn) Tissue Expression in Transgenic Mice by Online Peptide Immuno-Affinity LC-HRMS
- (2016) Yao-Yun Fan et al. ANALYTICAL CHEMISTRY
- Quantification of protein biomarkers in tissues: new capabilities with pellet digestion peptide immunoaffinity LC–MS/MS
- (2016) Hendrik Neubert et al. Bioanalysis
- The Pathogenesis and Therapy of Muscular Dystrophies
- (2015) Simon Guiraud et al. Annual Review of Genomics and Human Genetics
- The necessity of and strategies for improving confidence in the accuracy of western blots
- (2014) Rajeshwary Ghosh et al. Expert Review of Proteomics
- Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients
- (2014) Caroline Le Guiner et al. MOLECULAR THERAPY
- Dystrophin quantification: Biological and translational research implications
- (2014) K. Anthony et al. NEUROLOGY
- Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
- (2014) Thibaut Larcher et al. PLoS One
- Highly Specific and Sensitive Measurements of Human and Monkey Interleukin 21 Using Sequential Protein and Tryptic Peptide Immunoaffinity LC-MS/MS
- (2013) Joe Palandra et al. ANALYTICAL CHEMISTRY
- Dystrophin levels and clinical severity in Becker muscular dystrophy patients
- (2013) J. C. van den Bergen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Microdystrophin Ameliorates Muscular Dystrophy in the Canine Model of Duchenne Muscular Dystrophy
- (2013) Jin-Hong Shin et al. MOLECULAR THERAPY
- Sequential Protein and Peptide Immunoaffinity Capture for Mass Spectrometry-Based Quantification of Total Human β-Nerve Growth Factor
- (2012) Hendrik Neubert et al. ANALYTICAL CHEMISTRY
- Evidence-based path to newborn screening for duchenne muscular dystrophy
- (2012) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry
- (2012) Regine M. Schoenherr et al. PROTEOMICS
- Online High-Flow Peptide Immunoaffinity Enrichment and Nanoflow LC-MS/MS: Assay Development for Total Salivary Pepsin/Pepsinogen
- (2010) H. Neubert et al. CLINICAL CHEMISTRY
- A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in Dogs
- (2008) Yongping Yue et al. MOLECULAR THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started